In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: Predominant expansion of CD8+ T cells

Blood

Volumn 98, Issue 5, 2001, Pages 1506-1511

  Sakai, Jill A ^a   Nagai, Masahiro ^a   Brennan, Meghan B ^a   Mora, Carlos A ^a   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD4 ANTIGEN; CD8 ANTIGEN; KI 67 ANTIGEN; PROTEIN TAX[11-19]; TETRAMER; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ARTICLE; CELL CULTURE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS CELL INTERACTION; VIRUS LOAD;

EID: 0035469884     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.5.1506     Document Type: Article

References (35)

1. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031-1032.
2. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407-409.
3. Kubota R, Osame M, Jacobson S. Retrovirus: human T-cell lymphotropic virus type I-associated diseases and immune dysfunction. In: Cunningham MW, Fujinami RS, eds. Effects of Microbes on the Immune System. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:349-371.
4. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987;21:117-122.
5. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990;348:245-248.
6. Jacobson S, McFarlin DE, Robinson S, et al. HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann Neurol. 1992;32:651-657.
7. Parker CE, Daenke S, Nightingale S, Bangham CR. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology. 1992;188:628-636.
8. Jacobson S, Zaninovic V, Mora C, et al. Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Ann Neurol. 1988;23(suppl):S196-S200.
9. Usuku K, Sonoda S, Osame M, et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol. 1988;23(suppl):S143-S150.
10. Itoyama Y, Minato S, Kira J, et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology. 1988;38:1302-1307.
11. Matsumoto M, Sugimoto M, Nakashima H, et al. Spontaneous T cell proliferation and release of soluble interleukin-2 receptors in patients with HTLV-I-associated myelopathy. Am J Trop Med Hyg. 1990;42:365-373.
12. Ijichi S, Eiraku N, Osame M, et al. In vitro modulation of lymphocyte proliferation by prednisolone and interferon-alpha in patients with HTLV-I-associated myelopathy (HAM). J Neuroimmunol. 1989;23:175-178.
13. Lehky TJ, Levin MC, Kubota R, et al. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac. Ann Neurol. 1998;44:942-947.
14. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol. 1990;64:5682-5687.
15. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4:586-593.
16. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 1986;5:2883-2888.
17. Wano Y, Feinberg M, Hosking JB, Bogerd H, Greene WC. Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth. Proc Natl Acad Sci U S A. 1988;85:9733-9737.
18. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 2000;95:1386-1392.
19. Tendler CL, Greenberg SJ, Blattner WA, et al. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci U S A. 1990;87:5218-5222.
20. Ijichi S, Izumo S, Nagai M, Shinmyozu K, Hall WW, Osame M. Anti-viral and immunomodulatory effects of interferon-alpha on cultured lymphocytes from patients with human T lymphotropic virus type I-associated myelopathy (HAM/TSP). J Neuroimmunol. 1995;61:213-221.
21. Eiraku N, Ijichi S, Yashiki S, Osame, M, Sonoda S. Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM/TSP). J Neuroimmunol. 1992;37:223-228.
22. Carayon P, Bord A. Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J Immunol Methods. 1992;147:225-230.
23. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715.
24. Koenig S, Woods RM, Brewah YA, et al. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol. 1993;151:3874-3883.
25. Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE. Immunological studies in tropical spastic paraparesis. Ann Neurol. 1990;27:149-156.
26. + T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A. 1998;95:7568-7573.
27. + T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 2000;13:657-664.
28. + memory T cells by opposing cytokines. Science. 2000;288:675-678.
29. Wucherpennig KW, Hollsberg P, Richardson JH, Benjamin D, Hafler DA. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc Natl Acad Sci U S A. 1992;89:2110-2114.
30. + cells in patients with HTLV-I associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I proviral load. J Infect Dis. 2001;183:197-205.
31. Bangham CR. The immune response to HTLV-I. Curr Opin Immunol. 2000;12:397-402.
32. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5:512-517.
33. Ijichi S, Izumo S, Eiraku N, et al. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses. 1993;41:542-547.
34. Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1993;52:424-430.
35. Levin MC, Lehky TJ, Flerlage AN, et al. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N Engl J Med. 1997;336:839-845.